BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29040322)

  • 1. Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay.
    Meleis AM; Mahtabfar A; Danish S; Foty RA
    PLoS One; 2017; 12(10):e0186483. PubMed ID: 29040322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo.
    Nair M; Romero J; Mahtabfar A; Meleis AM; Foty RA; Corbett SA
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29443896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells.
    Shannon S; Vaca C; Jia D; Entersz I; Schaer A; Carcione J; Weaver M; Avidar Y; Pettit R; Nair M; Khan A; Foty RA
    PLoS One; 2015; 10(8):e0135951. PubMed ID: 26284619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teaching an Old Drug New Tricks: Dexamethasone as an In Vivo Inhibitor of Glioblastoma Dispersal.
    Carminucci A; Tejero R; Huang Y; Danish S; Friedel RH; Foty R
    Cureus; 2020 Apr; 12(4):e7749. PubMed ID: 32455066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole Reverses a Number of Undesirable Effects of Dexamethasone in Glioblastoma Cells.
    Keul J; Sperling S; Rohde V; Mielke D; Ninkovic M
    Anticancer Res; 2024 May; 44(5):1829-1835. PubMed ID: 38677733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM; Micca PL; Coderre JA
    Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel.
    Bayat N; Ebrahimi-Barough S; Norouzi-Javidan A; Saberi H; Tajerian R; Ardakan MMM; Shirian S; Ai A; Ai J
    Biomed Pharmacother; 2016 Dec; 84():1959-1966. PubMed ID: 27836464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
    Wang C; Tong X; Yang F
    Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone reduces tumor recurrence and metastasis after pancreatic tumor resection in SCID mice.
    Egberts JH; Schniewind B; Pätzold M; Kettler B; Tepel J; Kalthoff H; Trauzold A
    Cancer Biol Ther; 2008 Jul; 7(7):1044-50. PubMed ID: 18431088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin matrix assembly suppresses dispersal of glioblastoma cells.
    Sabari J; Lax D; Connors D; Brotman I; Mindrebo E; Butler C; Entersz I; Jia D; Foty RA
    PLoS One; 2011; 6(9):e24810. PubMed ID: 21980357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen.
    Wang LJ; Li J; Hao FR; Yuan Y; Li JY; Lu W; Zhou TY
    Acta Pharmacol Sin; 2016 Jun; 37(6):845-56. PubMed ID: 27133297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone.
    Kaup B; Schindler I; Knüpfer H; Schlenzka A; Preiss R; Knüpfer MM
    J Neurooncol; 2001 Jan; 51(2):105-10. PubMed ID: 11386406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of EGF and BFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensibility.
    Bajetto A; Porcile C; Pattarozzi A; Scotti L; Aceto A; Daga A; Barbieri F; Florio T
    J Biol Regul Homeost Agents; 2013; 27(1):143-54. PubMed ID: 23489694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR2-Blocking Has Context-Sensitive Effects on Rat Glioblastoma Cell Line Outgrowth (S635) in an Organotypic Rat Brain Slice Culture Depending on Microglia-Depletion (PLX5622) and Dexamethasone Treatment.
    Falter J; Lohmeier A; Eberl P; Stoerr EM; Koskimäki J; Falter L; Rossmann J; Mederer T; Schmidt NO; Proescholdt M
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone.
    Kunicka JE; Talle MA; Denhardt GH; Brown M; Prince LA; Goldstein G
    Cell Immunol; 1993 Jun; 149(1):39-49. PubMed ID: 8513511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
    Kanatani Y; Kasukabe T; Okabe-Kado J; Hayashi S; Yamamoto-Yamaguchi Y; Motoyoshi K; Nagata N; Honma Y
    Cell Growth Differ; 1996 Feb; 7(2):187-96. PubMed ID: 8822202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas.
    Benedetti S; Pirola B; Poliani PL; Cajola L; Pollo B; Bagnati R; Magrassi L; Tunici P; Finocchiaro G
    Gene Ther; 2003 Jan; 10(2):188-92. PubMed ID: 12571648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior.
    Alieva M; Margarido AS; Wieles T; Abels ER; Colak B; Boquetale C; Jan Noordmans H; Snijders TJ; Broekman ML; van Rheenen J
    Sci Rep; 2017 Aug; 7(1):7529. PubMed ID: 28790339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids inhibit somatostatin gene expression through accelerated degradation of somatostatin messenger ribonucleic acid in human thyroid medullary carcinoma (TT) cells.
    Liu JL; Patel YC
    Endocrinology; 1995 Jun; 136(6):2389-96. PubMed ID: 7750460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
    Roelcke U; Blasberg RG; von Ammon K; Hofer S; Vontobel P; Maguire RP; Radü EW; Herrmann R; Leenders KL
    J Nucl Med; 1998 May; 39(5):879-84. PubMed ID: 9591593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.